186 related articles for article (PubMed ID: 24748116)
21. A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis.
Moktan S; Ryppa C; Kratz F; Raucher D
Invest New Drugs; 2012 Feb; 30(1):236-48. PubMed ID: 20938714
[TBL] [Abstract][Full Text] [Related]
22. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
Zang X; Wang G; Cai Q; Zheng X; Zhang J; Chen Q; Wu B; Zhu X; Hao H; Zhou F
Drug Metab Dispos; 2018 May; 46(5):542-551. PubMed ID: 29523600
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
Flores ML; Castilla C; Ávila R; Ruiz-Borrego M; Sáez C; Japón MA
Breast Cancer Res Treat; 2012 Jun; 133(3):917-28. PubMed ID: 22076480
[TBL] [Abstract][Full Text] [Related]
24. Mechanical effects of EB1 on microtubules depend on GTP hydrolysis state and presence of paclitaxel.
Lopez BJ; Valentine MT
Cytoskeleton (Hoboken); 2014 Sep; 71(9):530-41. PubMed ID: 25160006
[TBL] [Abstract][Full Text] [Related]
25. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity.
Henley D; Isbill M; Fernando R; Foster JS; Wimalasena J
Cancer Chemother Pharmacol; 2007 Feb; 59(2):235-49. PubMed ID: 16972069
[TBL] [Abstract][Full Text] [Related]
27. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
Xiong H; Yu S; Zhuang L; Xiong H
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):65-7. PubMed ID: 17393113
[TBL] [Abstract][Full Text] [Related]
28. Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.
Hu P; Huang Q; Li Z; Wu X; Ouyang Q; Chen J; Cao Y
Mol Biol Rep; 2014 Jan; 41(1):19-24. PubMed ID: 24253898
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
Zhou Y; Inaba S; Liu J
Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
[TBL] [Abstract][Full Text] [Related]
30. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
Zeng WG; Li JJ; Hu P; Lei L; Wang JN; Liu RB
Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
[TBL] [Abstract][Full Text] [Related]
31. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
32. Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy.
Shi X; Sun X
Cancer Chemother Pharmacol; 2017 Nov; 80(5):909-917. PubMed ID: 28741098
[TBL] [Abstract][Full Text] [Related]
33. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
34. Role of gamma-synuclein in microtubule regulation.
Zhang H; Kouadio A; Cartledge D; Godwin AK
Exp Cell Res; 2011 Jun; 317(10):1330-9. PubMed ID: 20974125
[TBL] [Abstract][Full Text] [Related]
35. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.
Rouzier R; Rajan R; Wagner P; Hess KR; Gold DL; Stec J; Ayers M; Ross JS; Zhang P; Buchholz TA; Kuerer H; Green M; Arun B; Hortobagyi GN; Symmans WF; Pusztai L
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8315-20. PubMed ID: 15914550
[TBL] [Abstract][Full Text] [Related]
36. Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel.
Lin Y; Liu Z; Li Y; Liao X; Liao S; Cen S; Yang L; Wei J; Hu X
Biol Pharm Bull; 2013; 36(3):376-83. PubMed ID: 23229357
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
38. Eribulin targets a ch-TOG-dependent directed migration of cancer cells.
Chanez B; Gonçalves A; Badache A; Verdier-Pinard P
Oncotarget; 2015 Dec; 6(39):41667-78. PubMed ID: 26497677
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a dynamic interaction between two microtubule-binding proteins, EB1 and TIP150, by the mitotic p300/CBP-associated factor (PCAF) orchestrates kinetochore microtubule plasticity and chromosome stability during mitosis.
Ward T; Wang M; Liu X; Wang Z; Xia P; Chu Y; Wang X; Liu L; Jiang K; Yu H; Yan M; Wang J; Hill DL; Huang Y; Zhu T; Yao X
J Biol Chem; 2013 May; 288(22):15771-85. PubMed ID: 23595990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
